VYGR News | VYGR SEC Filings | VYGR Buzz |
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting Monday April 22, 2024
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment Tuesday April 16, 2024
Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? Tuesday April 09, 2024
Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs. Saturday March 30, 2024
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Tuesday March 26, 2024
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer Wednesday March 13, 2024
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds Saturday March 09, 2024
Analysts Just Made A Major Revision To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Forecasts Monday March 04, 2024
Q4 2023 Voyager Therapeutics Inc Earnings Call Thursday February 29, 2024
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript Thursday February 29, 2024
Voyager Therapeutics Inc (VYGR) Announces Strong Year-End Financials with Significant Cash Position Wednesday February 28, 2024
Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results Wednesday February 28, 2024
Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich's Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment Monday February 26, 2024
Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains? Monday February 26, 2024
Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast Wednesday February 21, 2024
Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer's Disease and Advances Program into Late Research Tuesday February 20, 2024
Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference Wednesday February 07, 2024
While institutions own 30% of Voyager Therapeutics, Inc. (NASDAQ:VYGR), individual investors are its largest shareholders with 42% ownership Friday January 26, 2024
Financial Frontrunners: 3 Stocks Where the Big Money Is Moving in 2024 Friday January 12, 2024
Voyager Therapeutics Announces Pricing of Public Offering Friday January 05, 2024